![Carl Dockery](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carl Dockery
Directeur/Bestuurslid bij
AYTU BIOPHARMA, INC.
Vermogen: 48 553 $ op 31-05-2026
Profiel
Mr. Carl C.
Dockery is an Independent Director at Aytu Biopharma, Inc. and a General Partner at Alpha Venture Capital Management LLC.
He is on the Board of Directors at Aytu Biopharma, Inc. Mr. Dockery was previously employed as an Independent Director by CytoDyn, Inc., a Secretary & Director by Crossroads Insurance Co. Ltd., a President by Alpha Advisors LLC, and a Vice President by Gulf Insurance Co. Ltd. He received his undergraduate degree from Southeastern University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 13-10-2025 | 21.202 ( 0,2% ) | 48 553 $ | 31-05-2026 |
Actieve functies van Carl Dockery
| Bedrijven | Functie | Begin |
|---|---|---|
| AYTU BIOPHARMA, INC. | Directeur/Bestuurslid | 13-04-2016 |
Alpha Venture Capital Management LLC
 Alpha Venture Capital Management LLC Investment ManagersFinance Alpha Venture Capital is an active manager which invests in companies located in the United States. It targets companies operating in the fields of biotech, renewable energy, cloud computing, nanotechnology, photonics, alternative fuel vehicles, clean energy and designer pharmaceuticals. It provides financing for later stage capital requirements. | Private Equity Investor | 02-02-2011 |
Eerdere bekende functies van Carl Dockery
| Bedrijven | Functie | Einde |
|---|---|---|
| CYTODYN INC. | Directeur/Bestuurslid | 12-09-2019 |
Crossroads Insurance Co. Ltd. | Directeur/Bestuurslid | 01-01-2008 |
Gulf Insurance Co. Ltd. | Corporate Officer/Principal | - |
Alpha Advisors LLC
 Alpha Advisors LLC Investment ManagersFinance Alpha Advisors’ investment philosophy embraces asset allocation as the main driver of portfolio returns, and diversification among asset classes and securities as the primary means of managing risk. They seek to determine the most appropriate portfolio allocation for a client given their goals and stated risk tolerance. The firm primarily uses no-load mutual funds which typically holds multiple underlying equity and/or fixed income positions that provide diversification. | Oprichter | - |
Opleiding van Carl Dockery
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
11
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
CytoDyn, Inc.
 CytoDyn, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and commercializes pharmaceutical products to treat human immunodeficiency virus infection | Health Technology |
Alpha Advisors LLC
Alpha Advisors LLC Investment ManagersFinance Alpha Advisors’ investment philosophy embraces asset allocation as the main driver of portfolio returns, and diversification among asset classes and securities as the primary means of managing risk. They seek to determine the most appropriate portfolio allocation for a client given their goals and stated risk tolerance. The firm primarily uses no-load mutual funds which typically holds multiple underlying equity and/or fixed income positions that provide diversification. | Finance |
Southeastern University
 Southeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alpha Venture Capital Management LLC
Alpha Venture Capital Management LLC Investment ManagersFinance Alpha Venture Capital is an active manager which invests in companies located in the United States. It targets companies operating in the fields of biotech, renewable energy, cloud computing, nanotechnology, photonics, alternative fuel vehicles, clean energy and designer pharmaceuticals. It provides financing for later stage capital requirements. | Finance |
Aytu Biopharma, Inc.
 Aytu Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Crossroads Insurance Co. Ltd. | |
Gulf Insurance Co. Ltd. |
